Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease.
Heart failure therapy, while well tested in the adult population, therapeutic interventions are less well defined in the pediatric population. Several treatment strategies are available for the adult patient with heart failure, thought few of these therapies have been proven in children. Morbidity and mortality in the pediatric population with a failing heart is significant, and rhythm management as well as strategies to improve hemodynamics are important in the care of these children. This review will address issues of rhythm management and resynchronization therapy in pediatric and congenital heart disease patients with heart failure.
Dubin
Anne M
AM
Stanford University, 750 Welch Rd., Suite 305, Palo Alto, CA 94304, USA. amdubin@stanford.edu
Berul
Charles I
CI
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000601:surgery; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial; D017115:Catheter Ablation; D002648:Child; D017147:Defibrillators, Implantable; D022062:Electrophysiologic Techniques, Cardiac; D006330:Heart Defects, Congenital / Q000628:therapy*; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D010138:Pacemaker, Artificial; D026902:Potassium Channel Blockers / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D026902:Potassium Channel Blockers